Croda is today hosting investor seminar focusing on Life Sciences

Croda International Plc
[shareaholic app="share_buttons" id_name="post_below_content"]

Croda International (CRDA), the name behind high performance ingredients and technologies that are relied on by industries and consumers everywhere, is today hosting an Investor Seminar in London on its Life Sciences sector.

Senior members of the Group’s management team will provide a comprehensive overview of the sector, with a particular focus on the Health Care business. The Life Sciences sector offers compelling organic growth opportunities in both Crop and Health Care, alongside a continued ambition to selectively invest additional capital in acquisitions in adjacent technologies.

Presentation materials will be made available today at www.croda.com/investors. In addition, a video recording of the event will be made available later this week at the same address. No new material disclosures will be made during the event.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    Croda International Plc's Q3 2024 sales rose to £407m, up 5% year-on-year. Despite currency challenges, full-year profit outlook remains steady.
    Croda International Plc appoints Stephen Oxley as Chief Financial Officer, bringing his extensive experience from Johnson Matthey and nearly 30 years at KPMG.
    Croda International Plc (LON:CRDA) appoints Ian Bull as Non-Executive Director effective 25 June 2024, bringing vast financial and board experience.

      Search

      Search